Sign In
Buy BNGO
$1.30
+0.0400 (+3.17%)
At Close: Jun 03, 2026
Why Fast-paced Mover Bionano Genomics (BNGO) Is a Great Choice for Value Investors
09:55am, Thursday, 28'th May 2026
Bionano Genomics (BNGO) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are sti
Bionano Announces Full Retirement of Outstanding Senior Secured Convertible Debentures
08:00am, Thursday, 28'th May 2026
SAN DIEGO, May 28, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it has fully retired and cancelled all outstanding Senior Secured Convertible Debentures (the "De
Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia
08:00am, Tuesday, 26'th May 2026
SAN DIEGO, May 26, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced publication of a peer-reviewed study in Modern Pathology showing that optical genome mapping (OGM) det
Bionano Genomics, Inc. (BNGO) Q1 2026 Earnings Call Transcript
07:00pm, Wednesday, 13'th May 2026
Bionano Genomics, Inc. (BNGO) Q1 2026 Earnings Call Transcript
Bionano Genomics, Inc. (BNGO) Reports Q1 Loss, Tops Revenue Estimates
06:36pm, Wednesday, 13'th May 2026
Bionano Genomics, Inc. (BNGO) came out with a quarterly loss of $0.76 per share versus the Zacks Consensus Estimate of a loss of $0.81. This compares to a loss of $1.15 per share a year ago.
Bionano Reports First Quarter 2026 Results and Provides a Business Update
04:05pm, Wednesday, 13'th May 2026
SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the first quarter ended March 31, 2026. "The Bionano business is healthy, with fi
Bionano Announces Leadership Transition
04:30pm, Wednesday, 06'th May 2026
SAN DIEGO, May 06, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Al Luderer, Ph.D., chairman of Bionano's Board of Directors, has been appointed interim president
Bionano Announces a 56% Increase in Publications Describing the Utility of OGM in Rare Diseases in Q1 2026 vs Q1 2025
08:00am, Tuesday, 05'th May 2026
Overall, studies show: OGM Can Resolve Previously Unresolved Rare Disease Cases OGM Can Serve as a Gold Standard Technique for Characterization of SVs OGM Can Complement Sequencing for Better SV Sensi
Bionano to Report First Quarter 2026 Financial Results and Host a Conference Call Webcast on May 13, 2026
04:05pm, Wednesday, 29'th Apr 2026
SAN DIEGO, April 29, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Wednesday, May 13, 2026, at 4:30 p.m. Easter
SAN DIEGO, April 02, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced the publication of a study in the American Journal of Hematology demonstrating that optical genome mappin
Bionano Genomics, Inc. (BNGO) Q4 2025 Earnings Call Transcript
07:33pm, Monday, 23'rd Mar 2026
Bionano Genomics, Inc. (BNGO) Q4 2025 Earnings Call Transcript
Bionano Genomics Stock Soars As Efficiency Gains Meet Growth Story
04:50pm, Monday, 23'rd Mar 2026
Despite a slight year-over-year revenue dip, the stock showed resilience, gaining nearly 27% in Monday's regular session.
Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026
04:05pm, Monday, 23'rd Mar 2026
SAN DIEGO, March 23, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2025. "2025 demonstrated th
Bionano Genomics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
03:54am, Friday, 20'th Mar 2026
Bionano Genomics, Inc. (NASDAQ: BNGO) will release earnings results for its fourth quarter, after the closing bell on Monday, March 23.
Bionano Genomics (BNGO) Projected to Post Quarterly Earnings on Monday
02:10am, Monday, 16'th Mar 2026
Bionano Genomics (NASDAQ: BNGO - Get Free Report) is anticipated to post its Q4 2025 results after the market closes on Monday, March 23rd. Analysts expect Bionano Genomics to post earnings of ($0.81)
